Tech Company Financing Transactions
Bardy Diagnostics Funding Round
Bardy Diagnostics, based in Seattle, secured $35.5 million from River Cities Capital Funds, Aperture Venture Partners and Aphelion Capital.
Transaction Overview
Company Name
Announced On
4/17/2019
Transaction Type
Venture Equity
Amount
$35,500,000
Round
Series B
Investors
River Cities Capital Funds (Lead Investor) (Rik Vandevenne)
HealthQuest Capital (Garheng Kong)
Proceeds Purpose
The funds will be used to further accelerate growth of its innovative P-wave focused cardiac monitoring platform through expansion of BardyDx's sales force and monitoring services, and to support advanced development programs, including augmented intelligence and visualization technologies.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
316 Occidental Ave. South B310
Seattle, WA 98104
USA
Seattle, WA 98104
USA
Phone
Website
Email Address
Overview
Bardy Diagnostics, Inc. (BDx) was founded to address a longstanding complaint in cardiac arrhythmia monitoring. Current monitors are large, bulky, uncomfortable (especially for women) and frequently record only noisy QRS signals. Clear P-waves are often not seen.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Gust Bardy
Chief Financial Officer
Mark Querry
Chief Operating Officer
Mark Handfelt
VP - Bus. Development
Ken Nelson
VP - Engineering
Chuck Dulken
VP - Sales
Bobby Cockrill
Browse more venture capital transactions:
Prev: 4/17/2019: MyVillage venture capital transaction
Next: 4/17/2019: Complexa venture capital transaction
Share this article
News on VC Transactions
Our team works diligently to report on every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs